Silvia Díaz‐Cerezo
Silvia Díaz‐Cerezo publishes mostly in Endocrinology, Diabetes and Metabolism, Rheumatology and Psychiatry and Mental health, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Rheumatoid Arthritis Research and Therapies.
- World rank
- #3,746,482 of 7,710,434 ranked researchers
- Rank in Spain
- #85,196 of 204,306
- Works
- 89
- Citations
- 849
- Citations per work
- 9.5
What does Silvia Díaz‐Cerezo research?
Silvia Díaz‐Cerezo's work is mostly in Medicine (50%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4449.9%
- Medicine4449.9%
- Everything else4045.3%
- Life Sciences44.8%
- 1Endocrinology, Diabetes and Metabolism24% of their works
- 2Rheumatology11% of their works
- 3Psychiatry and Mental health7% of their works
- 4Pulmonary and Respiratory Medicine5% of their works
- 5Immunology5% of their works
- 6Dermatology4% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes Management and Research
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Migraine and Headache Studies
- Psoriasis: Treatment and Pathogenesis
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
Which keywords describe Silvia Díaz‐Cerezo's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cardiovascular Disease, Diabetes, Cardiovascular Outcomes, Type 2 Diabetes, Continuous Glucose Monitoring and Hypoglycemia.
- TH17 Cells
- Insulin Resistance
- Hyperglycemia
- Migraine
- Spondyloarthritis
- Rheumatoid Arthritis
- Hypoglycemia
- Type 2 Diabetes
- Diabetes
- Insulin Therapy
- Glycemic Control
- Cardiovascular Disease
- Cardiovascular Outcomes
- Continuous Glucose Monitoring
- Inflammation
- Ankylosing Spondylitis
- Headache Disorders
- Critical Care
- IL-17
- Metabolic Syndrome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Glycemic Control443 topics
- Insulin Therapy443 topics
- Cardiovascular Disease242 topics
- Diabetes242 topics
- Cardiovascular Outcomes201 topic
- Type 2 Diabetes201 topic
- Continuous Glucose Monitoring161 topic
- Hypoglycemia161 topic
- Inflammation111 topic
- Rheumatoid Arthritis111 topic
- Ankylosing Spondylitis101 topic
- Spondyloarthritis101 topic
- Headache Disorders91 topic
- Migraine91 topic
- Critical Care81 topic
- Hyperglycemia81 topic
- IL-1781 topic
- Insulin Resistance81 topic
- Metabolic Syndrome81 topic
- TH17 Cells81 topic
Where does Silvia Díaz‐Cerezo work?
Silvia Díaz‐Cerezo's main affiliation in the publication record is Eli Lilly (Spain), Spain.
How many publications and citations does Silvia Díaz‐Cerezo have?
OpenAlex counts 89 works and 849 citations for Silvia Díaz‐Cerezo, an h-index of 16, ranking #3,746,482 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Silvia Díaz‐Cerezo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.